FDA panel votes Abbott's Humira has meaningful benefit for ulcerative colitis

RELATED QUOTES

SymbolPriceChange
ABT37.811.22

FDA advisory panel voting reported by Bloomberg. The panel also voted that Abbott has not found the appropriate dose for Humira in this indication, according to Bloomberg.

  •  
    Recent Quotes
    Symbol Price Change % ChgChart 
    Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
    You need to enable your browser cookies to view your most recent quotes.
  • Recent Quotes News

    •  
      Sign-in to view quotes in your portfolios.

    Trading Center

    Yahoo! Finance on Facebook

    POLL

    Do you trust the IRS in light of its recent scandals?

    Loading...
    Poll Choice Options